REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 117 filers reported holding REVOLUTION MEDICINES INC in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $585,535 | -74.4% | 27,033 | -71.9% | 0.00% | -76.9% |
| Q4 2022 | $2,289,340 | -53.7% | 96,110 | -61.6% | 0.01% | -51.9% |
| Q3 2022 | $4,941,000 | +126.1% | 250,571 | +123.5% | 0.03% | +145.5% |
| Q2 2022 | $2,185,000 | -7.7% | 112,134 | +20.8% | 0.01% | -15.4% |
| Q1 2022 | $2,368,000 | +61.2% | 92,825 | +73.9% | 0.01% | +44.4% |
| Q3 2021 | $1,469,000 | +237.7% | 53,384 | +289.6% | 0.01% | +200.0% |
| Q2 2021 | $435,000 | -81.1% | 13,701 | -72.7% | 0.00% | -82.4% |
| Q1 2021 | $2,300,000 | -33.5% | 50,141 | -42.6% | 0.02% | -41.4% |
| Q4 2020 | $3,458,000 | – | 87,335 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 685,011 | $13,508,000 | 35.31% |
| TRV GP III, LLC | 3,604,130 | $71,073,000 | 31.03% |
| Nextech Invest Ltd. | 4,189,529 | $82,618,000 | 26.68% |
| Column Group LLC | 4,577,840 | $90,275,000 | 19.98% |
| Ponoi Management, LLC | 685,011 | $13,508,000 | 18.44% |
| TRV GP IV, LLC | 1,419,900 | $28,000,000 | 16.36% |
| Boxer Capital, LLC | 3,984,264 | $78,570,000 | 4.42% |
| Casdin Capital, LLC | 2,522,300 | $49,740,000 | 3.27% |
| Cormorant Asset Management, LP | 1,995,066 | $39,343,000 | 2.75% |
| BVF INC/IL | 3,255,588 | $64,200,000 | 2.65% |